Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis
Status:
Completed
Trial end date:
2020-06-02
Target enrollment:
Participant gender:
Summary
An abnormal intestinal microbiota may be the mediator of the common inflammatory pathways
seen in psoriatic arthritis. This study will explore clinical aspects associated with
modifying the intestinal microbiota by infusing fecal donor microbiota into the small
intestine of psoriatic arthritis patients with a minimum of three swollen joints despite at
least three months of methotrexate treatment.
Phase:
N/A
Details
Lead Sponsor:
Odense University Hospital
Collaborators:
Manufacturer Vilhelm Pedersen Foundation Odense Patient Data Explorative Network Odense Patient Explorative data Network (OPEN) Region of Southern Denmark The Danish Regions (Medicinpuljen) The Danish Rheumatism Association The Psoriasis Association, Denmark University of Southern Denmark